These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 219129)
21. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Newmaster RS; Mylin LM; Fu TM; Tevethia SS Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511 [TBL] [Abstract][Full Text] [Related]
22. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea. Einstein AB; Fass L; Fefer A Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784 [TBL] [Abstract][Full Text] [Related]
23. A requirement for three cell types for in vitro generation of specific secondary cell-mediated cytotoxic response against SV40-induced tumor-associated antigens in mice. Glaser M Cell Immunol; 1980 Feb; 49(2):415-20. PubMed ID: 6243517 [No Abstract] [Full Text] [Related]
24. Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in mice. Glaser M Eur J Immunol; 1980 Jul; 10(7):489-95. PubMed ID: 6250855 [No Abstract] [Full Text] [Related]
25. Immunopathology of polyoma-induced tumors. Vandeputte M Springer Semin Immunopathol; 1982; 4(4):317-32. PubMed ID: 6293109 [No Abstract] [Full Text] [Related]
26. Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes. Gooding LR J Immunol; 1980 Apr; 124(4):1612-9. PubMed ID: 6245126 [No Abstract] [Full Text] [Related]
27. Induction of simian virus 40-specific tumour rejection by the Ad2+ND2 hybrid virus. Jay G; Jay FT; Chang C; Levine AS; Friedman RM J Gen Virol; 1979 Aug; 44(2):287-96. PubMed ID: 230283 [TBL] [Abstract][Full Text] [Related]
28. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
29. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex. Gooding LR J Immunol; 1979 Mar; 122(3):1002-8. PubMed ID: 87414 [TBL] [Abstract][Full Text] [Related]
30. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Bright RK; Beames B; Shearer MH; Kennedy RC Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771 [TBL] [Abstract][Full Text] [Related]
31. Immune response to polyoma tumor cells in mice. I. Magnitude and specificity of the in vitro cellular cytotoxicity elicited by immunization with graded numbers of tumor cells. Walia AS; Lamon EW J Natl Cancer Inst; 1977 Jun; 58(6):1671-5. PubMed ID: 194042 [No Abstract] [Full Text] [Related]
32. Macrophage requirement for in vitro generation of specific, secondary cell-mediated cytotoxicity against SV 40-induced tumor-associated antigens in mice. Glaser M Eur J Immunol; 1980 May; 10(5):342-6. PubMed ID: 6250854 [TBL] [Abstract][Full Text] [Related]
33. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VIII. Retention of SV40 TrAg sites on purified SV40 large T antigen following denaturation with sodium dodecyl sulfate. Flyer DC; Tevethia SS Virology; 1982 Feb; 117(1):267-70. PubMed ID: 6175086 [No Abstract] [Full Text] [Related]
34. Mechanisms of immunological response induced in CD2F1 mice by administration of semisyngeneic L 1210 leukemia cells treated with cyclophosphamide. Skórski T; Kawalec M; Kawiak J Immunol Invest; 1987 Mar; 16(1):33-43. PubMed ID: 2956188 [TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens. Bonavida B; Hutchinson IV; Thomas A Transplant Proc; 1979 Mar; 11(1):874-7. PubMed ID: 313108 [TBL] [Abstract][Full Text] [Related]
36. Genetic differences in the cyclophosphamide-induced immune suppression: weaker suppression of T-cell cytotoxicity by cyclophosphamide activated by CBA mice. Hurme M; Bång BE; Sihvola M Clin Immunol Immunopathol; 1980 Sep; 17(1):38-42. PubMed ID: 6967785 [No Abstract] [Full Text] [Related]
37. Effect of cyclophosphamide and methylprednisolone on in vitro cellular immune response to allogeneic tumor cells. Correlation with in vivo rejection. Gerber M; Andress D; Pioch Y; Radal M; Serrou B Transplantation; 1978 Sep; 26(3):142-9. PubMed ID: 309196 [No Abstract] [Full Text] [Related]
38. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells. Fresa KL; Karjalainen HE; Tevethia SS J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174 [TBL] [Abstract][Full Text] [Related]
39. Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells. Lange-Mutschler J; Deppert W; Hanke K; Henning R J Gen Virol; 1981 Feb; 52(Pt 2):301-12. PubMed ID: 6270237 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk. Gooding LR J Immunol; 1982 Sep; 129(3):1306-12. PubMed ID: 6286762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]